Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CVT 510

Known as: CVT-510 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Termination of Paroxysmal Supraventricular Tachycardia by Tecadenoson (CVT-510), a Novel A1-Adenosine Receptor Agonist Eric N… Expand
  • figure 1
  • table 1
  • table 2
Is this relevant?
2013
2013
Selective pharmacological activation of the adenosine 1 receptor (A1R) is a promising new approach to achieve a potent block of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2010
2010
Publication of this article is suspended until the authors can provide full identification and verification of the chemical… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2003
2003
OBJECTIVES The aim of this study was to evaluate tecadenoson safety and efficacy during conversion of paroxysmal supraventricular… Expand
Is this relevant?
Review
2003
Review
2003
Adenosine is an endogenous nucleoside that has potent antiarrhythmic effects on paroxysmal supraventricular tachycardia (PSVT… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2003
2003
Elevated serum nonesterified free fatty acid (NEFA) concentrations are detrimental to both the mechanical and electrical function… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 5
  • figure 4
Is this relevant?
Review
2002
Review
2002
  • A. Zaza
  • Current opinion in investigational drugs
  • 2002
  • Corpus ID: 33013187
CVT-510, the lead compound from a series of selective adenosine A1 receptor agonists, is being developed by CV Therapeutics for… Expand
Is this relevant?
2001
2001
Background: CVT-510, N-(3(R)-tetrahydrofuranyl)-6-aminopurine riboside, is a selective A,-adenosine receptor agonist with… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2001
2001
CVT‐510 (N‐(3(R)‐tetrahydrofuranyl)‐6‐aminopurine riboside), a selective A1 adenosine receptor (AdoR) agonist, is being developed… Expand
Is this relevant?
1999
1999
The purpose of this study was to compare the pharmacological properties (i.e. the AV nodal depressant, vasodilator, and inotropic… Expand
Is this relevant?